Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Old Dominion Freight Line
ODFL
|
+$458M |
| 2 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$248M |
| 3 |
Palo Alto Networks
PANW
|
+$163M |
| 4 |
TSMC
TSM
|
+$150M |
| 5 |
iShares MSCI Emerging Markets ex China ETF
EMXC
|
+$149M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$944M |
| 2 |
Apple
AAPL
|
+$521M |
| 3 |
Booking.com
BKNG
|
+$283M |
| 4 |
Merck
MRK
|
+$276M |
| 5 |
Procter & Gamble
PG
|
+$261M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.11% |
| 2 | Healthcare | 13.13% |
| 3 | Financials | 11.12% |
| 4 | Consumer Discretionary | 9.91% |
| 5 | Industrials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4001
Akebia Therapeutics
AKBA
$241M
| $65.7K | ﹤0.01% |
71,836
| – | – |
|
4002
CEL-SCI Corp
CVM
$26M
| $65.7K | ﹤0.01% |
909
-2
| -0.2% | -$146 |
|
4003
Curis
CRIS
$3.91M
| $64.7K | ﹤0.01% |
195
-1
| -0.5% | -$325 |
|
|
MKFG
4004
DELISTED
Markforged Holding Corporation
MKFG
| $64K | ﹤0.01% |
5,289
-29,018
| -85% | -$273K |
|
4005
Apyx Medical
APYX
$128M
| $63.8K | ﹤0.01% |
12,682
-8,068
| -39% | -$40.9K |
|
|
SEEL
4006
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
| $63.2K | ﹤0.01% |
14
| – | – |
|
|
TRML
4007
DELISTED
Tourmaline Bio
TRML
| $62.9K | ﹤0.01% |
2,069
-3,787
| -65% | -$96.7K |
|
4008
Applied Optoelectronics
AAOI
$11B
| $62.9K | ﹤0.01% |
10,551
| – | – |
|
|
ASXC
4009
DELISTED
Asensus Surgical, Inc.
ASXC
| $62.7K | ﹤0.01% |
124,169
| – | – |
|
|
RPT
4010
Rithm Property Trust
RPT
$101M
| $62.3K | ﹤0.01% |
1,695
| – | – |
|
4011
Hudbay
HBM
$11.8B
| $62K | ﹤0.01% |
12,916
+2,350
| +22% | +$11.5K |
|
|
ATXI
4012
DELISTED
Avenue Therapeutics, Inc. Common Stock
ATXI
| $62K | ﹤0.01% |
706
-6
| -0.8% | -$494 |
|
|
SCTL
4013
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $61.9K | ﹤0.01% |
56,298
| – | – |
|
4014
Phunware
PHUN
$43.4M
| $61.9K | ﹤0.01% |
2,291
-10
| -0.4% | -$306 |
|
4015
Groupon
GRPN
$894M
| $61.4K | ﹤0.01% |
10,389
-67,488
| -87% | -$299K |
|
4016
C4 Therapeutics
CCCC
$502M
| $61.3K | ﹤0.01% |
22,281
-129,276
| -85% | -$416K |
|
4017
Jasper Therapeutics
JSPR
$28.7M
| $59.7K | ﹤0.01% |
4,359
| – | – |
|
4018
Matinas BioPharma
MTNB
$1.49M
| $59.4K | ﹤0.01% |
3,303
-10
| -0.3% | -$233 |
|
4019
First Majestic Silver
AG
$9.26B
| $59.4K | ﹤0.01% |
10,510
| – | – |
|
4020
Achieve Life Sciences
ACHV
$744M
| $59.4K | ﹤0.01% |
11,441
-231
| -2% | -$1.62K |
|
4021
Inovio Pharmaceuticals
INO
$93M
| $59.3K | ﹤0.01% |
11,071
-61,808
| -85% | -$498K |
|
4022
Orion Energy Systems
OESX
$78.9M
| $58.8K | ﹤0.01% |
3,610
-14
| -0.4% | -$229 |
|
|
LX
4023
LexinFintech Holdings
LX
$236M
| $58.8K | ﹤0.01% |
25,692
-2,644
| -9% | -$6.41K |
|
4024
Genasys
GNSS
$77.9M
| $58.4K | ﹤0.01% |
22,469
| – | – |
|
|
EMAN
4025
DELISTED
eMagin Corporation
EMAN
| $58.4K | ﹤0.01% |
29,503
-17,970
| -38% | -$35.4K |
|
Similar funds
Bank of New York Mellon's Q2 2023 Portfolio in Review
As of Q2 2023, Bank of New York Mellon held 4,580 positions worth $476B, up 4.2% from $457B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Bank of New York Mellon's Q2 2023 filing shows 192 new, 1,611 increased, 2,315 reduced and 201 closed positions. Its largest new stake was Kenvue: 4,155,782 shares worth $110M. The largest sale was Microsoft, an estimated $944M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q2 2023 buy was Kenvue: 4,155,782 shares worth $110M.
- Bank of New York Mellon added most to Old Dominion Freight Line in Q2 2023, an estimated $458M increase.
- Bank of New York Mellon's biggest Q2 2023 reduction was Microsoft, cutting an estimated $944M.
- Bank of New York Mellon fully exited Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6.00% Mandatory Convertible Preferred Stock, Series B in Q2 2023, selling an estimated $57.6M.
- Bank of New York Mellon's ten largest holdings make up 21% of its $476B portfolio in Q2 2023.
- Bank of New York Mellon opened 192 new positions and closed 201 in Q2 2023.
- Bank of New York Mellon's portfolio value rose 4.2% quarter-over-quarter to $476B.
Based on Bank of New York Mellon's 13F filing for Q2 2023, filed 3 Aug 2023.